Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Research at Astellas yields novel phosphodiesterase 9A inhibitors

April 11, 2012

FDA advisory committee issues recommendation on Astellas' mirabegron

April 10, 2012

Astellas Pharma discloses new phosphodiesterase 9A inhibitors

April 5, 2012

AlloCure raises funds to support AC-607 development

April 4, 2012

Minirinmelt tablets approved in Japan

April 3, 2012

Toray and Taiho discontinue codevelopment of beta3-adrenoceptor agonist

March 30, 2012

Kiklin capsules approved in Japan

March 30, 2012

Trillium Therapeutics doses first patient in phase I trial of TTI-1612

March 29, 2012

Allergan seeks approval for line extension of Botox

March 29, 2012

Protox advances PRX-302 trial

March 29, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...